Metastatic Melanoma Clinical Trials in Ljubljana
2 recruitingLjubljana, Slovenia
Showing 1–2 of 2 trials
Recruiting
Not Applicable
Immunotherapy Efficacy and PD-L1 as a Predictive Biomarker in Metastatic Melanoma in Slovenia
Metastatic MelanomaSkin Cancer
Institute of Oncology Ljubljana100 enrolled1 locationNCT07422779
Recruiting
Not Applicable
Biomarkers in Immunotherapy of Melanoma
Metastatic MelanomaImmune Checkpoints InhibitorsGastrointestinal Microbiome (Bacterial and Viral)+1 more
Institute of Oncology Ljubljana150 enrolled1 locationNCT05878977